This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2019-2023.
Company Filing History:
Years Active: 2019-2023
Title: John T. Liles: Innovator in Liver Disease Treatment
Introduction
John T. Liles is a notable inventor based in San Jose, CA, who has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. With a total of 2 patents to his name, Liles is dedicated to advancing healthcare through innovative solutions.
Latest Patents
Liles' latest patents focus on methods of treating liver disease. The first patent discloses a method of preventing and/or treating liver disease by administering an ACC inhibitor in combination with an FXR agonist to a patient in need thereof. The second patent also addresses liver disease treatment, detailing a method that involves administering an ASK1 inhibitor in combination with an FXR agonist to a patient in need thereof. These patents reflect his commitment to finding effective therapies for liver conditions.
Career Highlights
John T. Liles is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on innovative medicines. His work at Gilead has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of Liles' notable coworkers include Jamie Geier Bates and David Gordon Clarkson Breckenridge. Their collaborative efforts have likely enhanced the research and development of new treatments in the pharmaceutical industry.
Conclusion
John T. Liles is a dedicated inventor whose work in liver disease treatment showcases his innovative spirit and commitment to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of continued research and development in medicine.